Facilitating Access to Approved Medication

Olutasidenib Capsules
olutasidenib capsules is a prescription medicine used to treat relapsed or refractory acute myeloid leukemia with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation

Get Access To Olutasidenib Capsules

OLUTASIDENIB For Injection available, genuine price cost in India US UK AE SA BR RU CN

olutasidenib capsules, for oral use

  • API: olutasidenib
  • Trade Name: On Request
  • Packaging: capsules, for oral use
  • Strength: Capsules: 150 mg
  • Indications:

WHAT IS OLUTASIDENIB AND WHAT IT IS USED FOR?

Olutasidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test. Olutasidenib was approved for medical use in the United States in December 2022.

Note: (see Drugs@FDA for complete indication)

    Disclaimer

    All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.